Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Published online before print October 26, 2005, 10.1148/radiol.2373040966
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2373040966v1
237/3/803    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Munden, R. F.
Right arrow Articles by Stewart, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Munden, R. F.
Right arrow Articles by Stewart, D. J.
(Radiology 2005;237:803-818.)
© RSNA, 2005

What the Clinician Wants to Know

Imaging of the Patient with Non–Small Cell Lung Cancer1

Reginald F. Munden, MD, DMD, Stephen S. Swisher, MD, Craig W. Stevens, MD, PhD and David J. Stewart, MD

1 From the Division of Diagnostic Imaging, Department of Diagnostic Radiology (R.F.M.), Department of Thoracic and Cardiovascular Surgery (S.S.S.), Division of Radiation Oncology (C.W.S.), and Division of Cancer Medicine (D.J.S.), University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030. Received June 2, 2004; revision requested August 12; revision received October 27; accepted December 15. Address correspondence to R.F.M. (e-mail: rmunden{at}di.mdacc.tmc.edu).

Lung cancer is the most common type of cancer and is the leading cause of cancer deaths in the United States for both men and women. Even though the 5-year survival rate of patients with lung cancer remains dismal at 14% for all cancer stages, treatments are improving and newer agents for lung cancer appear promising. Therefore, an accurate assessment of the extent of disease is critical to determine whether the patient is treated with surgical resection, radiation therapy, chemotherapy, or a combination of these modalities. Radiologic imaging plays an important role in the staging evaluation of the patient; however, radiologists need to be aware that there are also important differences in what each specialist needs from imaging to provide appropriate treatment. This article reviews the role of imaging in patients with non–small cell lung cancer, with an emphasis on the radiologic imaging findings relevant for each specialty.

© RSNA, 2005




This article has been cited by other articles:


Home page
 Eur Respir JHome page
W. De Wever, S. Stroobants, J. Coolen, and J. A. Verschakelen
Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration
Eur. Respir. J., January 1, 2009; 33(1): 201 - 212.
[Abstract] [Full Text] [PDF]